Stockreport

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

Climb Bio, Inc.  (CLYM) 
PDF WELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair [Read more]